0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Nephrotoxicity of Common Drugs Used in Clinical Practice

Patricia L. Forrester, PharmD; Morton P. Goldman, PharmD
Arch Intern Med. 1988;148(1):237. doi:10.1001/archinte.1988.00380010239027.
Text Size: A A A
Published online

To the Editor.  —We read with interest the article by Cooper and Bennett, on drug-induced nephrotoxicity, which appeared in the July 1987 issue of the Archives.1 The authors should be commended on the excellent and thoroughly detailed review of this complex subject, in particular, the explanation regarding aminoglycoside-induced renal dysfunction. Although dosing recommendations were a minor portion of the article, there are a few areas regarding aminoglycoside dosing that we would like to address.The authors' recommended maintenance dose of aminoglycosides (1.0 mg/kg of body weight [approximately 3.0 mg/kg/d]) may not be sufficient to produce "therapeutic" peak serum concentrations, especially in critically ill patients and patients with respiratory infections. A study by Zaske et al2 demonstrated an average maintenance dose requirement of 4.5 mg/kg/d of gentamicin to obtain peaks of 6.9 μg/mL. Peak gentamicin/ tobramycin concentrations of greater than 4.0 to 5.0 μg/mL achieved early in therapy have

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();